This study investigated psychosensory symptoms and their relationship
to retrospective and prospective courses of illness, as well as therap
eutic outcomes, in patients with bipolar disorder. Using the Silberman
-Post Psychosensory Rating Scale (SP-PSRS), psychosensory symptoms wer
e assessed in 51 patients who met Diagnostic and Statistical Manual, 3
rd Edition-Revised (DSM-III-R) criteria for bipolar disorder and in 39
healthy, normal controls. Patients with bipolar disorder were enrolle
d in a 3-year, double-blind, randomized study comparing the prophylact
ic efficacy of lithium or carbamazepine in the first year, a crossover
to the other drug in the second year, and the combination of both med
ications in the third year. Psychosensory scores from patients with bi
polar disorder were compared with scores from healthy controls and wit
h a variety of retrospective and prospective course of illness and tre
atment variables. Psychosensory symptoms occurred frequently in patien
ts with bipolar I and II disorders, but were rare in healthy controls.
When depressed, patients with bipolar II disorder (n = 23) reported m
ore psychosensory symptoms when compared to patients with bipolar I di
sorder (n = 28), and those with a history of rapid cycling (n = 29) re
ported more psychosensory symptoms when compared to patients without a
history of rapid cycling (n = 21). Psychosensory symptoms were not re
lated to response to carbamazepine, lithium, or the combination of bot
h drugs. Although the presence of psychosensory symptoms is associated
with some bipolar subtypes (patients with bipolar II disorder and pat
ients with a history of rapid cycling), they do not appear to predict
treatment response. Further studies are needed to assess the pathophys
iologic implications of the presence of psychosensory symptoms and the
ir potential implications, if any, for directing therapeutics.